Abiopharma

🔍 Grossman Jerrold B (Executive)

Company: ADMA BIOLOGICS, INC. (ADMA)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Common Stock at $8.01 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 501,384.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 22,857.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 31,381.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 38,294.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 175.00 | Footnotes: F6

Footnotes:

• F1: Represents an open market purchase in a single transaction.
• F2: Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 490,694 shares of common stock owned by the reporting person.
• F3: These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood.
• F4: These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
• F5: These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis.
• F6: These shares are owned by the Reporting Person's wife.